These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. Gallagher JC; Riggs BL; Jerpbak CM; Arnaud CD J Lab Clin Med; 1980 Mar; 95(3):373-85. PubMed ID: 7354241 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure. Gautvik KM; Gautvik VT; Halvorsen JF Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid function and vitamin D status in patients with bone metastases of prostatic origin. Charhon SA; Chapuy MC; Delvin EE; Meunier PJ Miner Electrolyte Metab; 1985; 11(2):117-22. PubMed ID: 3838794 [TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone: radioimmunoassay and clinical interpretation. Hawker CD Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481 [TBL] [Abstract][Full Text] [Related]
8. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism. Gautvik KM; Teig V; Halvorsen JF; Arnesen E; Myhre L; Heimann P; Tollman R Scand J Clin Lab Invest; 1979 Sep; 39(5):469-78. PubMed ID: 574982 [TBL] [Abstract][Full Text] [Related]
9. PTH bioactivity in osteoporosis. Saphier PW; Stamp TC; Kelsey CR; Loveridge N Bone Miner; 1987 Oct; 3(1):75-83. PubMed ID: 3505195 [TBL] [Abstract][Full Text] [Related]
10. Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility. Goldsmith RS; Furszyfer J; Johnson WJ; Fournier AE; Sizemore GW; Arnaud CD J Clin Invest; 1973 Jan; 52(1):173-80. PubMed ID: 4734166 [TBL] [Abstract][Full Text] [Related]
11. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels. Starr FL; DeCresce R; Prinz RA Surgery; 2000 Dec; 128(6):930-5;discussion 935-6. PubMed ID: 11114626 [TBL] [Abstract][Full Text] [Related]
12. [Values and limitations of the radioimmunological determination of plasma parathyroid hormone in the study of the functional activity of the parathyroid glands]. Scarda A; D'Erasmo E; Malaguti Aliberti L; Mancini D; Mazzuoli GF Boll Soc Ital Biol Sper; 1979 Apr; 55(7):647-53. PubMed ID: 550892 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-biochemical parallels in diverse forms of primary hyperparathyroidism]. Fekson EG; Tishenina RS; Podobedova LI Klin Med (Mosk); 1989 Sep; 67(9):92-6. PubMed ID: 2586052 [TBL] [Abstract][Full Text] [Related]
14. Normocalcemic hyperparathyroidism in patients with osteoporosis. Monchik JM; Gorgun E Surgery; 2004 Dec; 136(6):1242-6. PubMed ID: 15657582 [TBL] [Abstract][Full Text] [Related]
15. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043 [TBL] [Abstract][Full Text] [Related]